These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells. Le HH; Cinaroglu SS; Manalo EC; Ors A; Gomes MM; Duan Sahbaz B; Bonic K; Origel Marmolejo CA; Quentel A; Plaut JS; Kawashima TE; Ozdemir ES; Malhotra SV; Ahiska Y; Sezerman U; Bayram Akcapinar G; Saldivar JC; Timucin E; Fischer JM EBioMedicine; 2021 Nov; 73():103646. PubMed ID: 34689087 [TBL] [Abstract][Full Text] [Related]
9. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. Khalil R; Diab-Assaf M; Lemaitre JM Cells; 2023 Mar; 12(6):. PubMed ID: 36980256 [TBL] [Abstract][Full Text] [Related]
10. Senolytic Therapy Enabled by Senescent Cell-Sensitive Biomimetic Melanin Nano-Senolytics. Zhang H; Xu X; Shou X; Liao W; Jin C; Chen C; Zhang C; Gao W; Zhang J; Ge W; Shi L Adv Healthc Mater; 2024 Sep; 13(23):e2401085. PubMed ID: 38796738 [TBL] [Abstract][Full Text] [Related]
11. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells. Murakami T; Inagaki N; Kondoh H Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205 [TBL] [Abstract][Full Text] [Related]
12. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions. Saleh T; Carpenter VJ Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896 [TBL] [Abstract][Full Text] [Related]
13. From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs. L'Hôte V; Mann C; Thuret JY Open Biol; 2022 Sep; 12(9):220171. PubMed ID: 36128715 [TBL] [Abstract][Full Text] [Related]
14. A guide to senolytic intervention in neurodegenerative disease. Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838 [TBL] [Abstract][Full Text] [Related]
15. Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity. González-Gualda E; Pàez-Ribes M; Lozano-Torres B; Macias D; Wilson JR; González-López C; Ou HL; Mirón-Barroso S; Zhang Z; Lérida-Viso A; Blandez JF; Bernardos A; Sancenón F; Rovira M; Fruk L; Martins CP; Serrano M; Doherty GJ; Martínez-Máñez R; Muñoz-Espín D Aging Cell; 2020 Apr; 19(4):e13142. PubMed ID: 32233024 [TBL] [Abstract][Full Text] [Related]
16. Senolysis Enabled by Senescent Cell-Sensitive Bioorthogonal Tetrazine Ligation. Chang M; Dong Y; Xu H; Cruickshank-Taylor AB; Kozora JS; Behpour B; Wang W Angew Chem Int Ed Engl; 2024 Feb; 63(9):e202315425. PubMed ID: 38233359 [TBL] [Abstract][Full Text] [Related]
17. Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker. Poblocka M; Bassey AL; Smith VM; Falcicchio M; Manso AS; Althubiti M; Sheng X; Kyle A; Barber R; Frigerio M; Macip S Sci Rep; 2021 Oct; 11(1):20358. PubMed ID: 34645909 [TBL] [Abstract][Full Text] [Related]
18. Addition of Polyphenols to Drugs: The Potential of Controlling "Inflammaging" and Fibrosis in Human Senescent Lung Fibroblasts In Vitro. Godoy MCX; Monteiro GA; Moraes BH; Macedo JA; Gonçalves GMS; Gambero A Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000270 [TBL] [Abstract][Full Text] [Related]